- Lexicon Pharmaceuticals (NASDAQ:LXRX): Q3 EPS of -$0.06 misses by $0.05.
- Revenue of $0.2M (-36% Y/Y) misses by $1.39M. (PR)
Lexicon Pharmaceuticals misses by $0.05, misses on revenues
Recommended For You
More Trending News
About LXRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| LXRX | - | - |
| Lexicon Pharmaceuticals, Inc. | ||